Playing with cardiac redox switches: The HNO way to modulate cardiac function

Antioxidants and Redox Signaling

Volumn 14, Issue 9, 2011, Pages 1687-1698

  Tocchetti, Carlo G ^a,b   Stanley, Brian A ^a   Murray, Christopher I ^a   Sivakumaran, Vidhya ^a   Donzelli, Sonia ^c   Mancardi, Daniele ^d   Pagliaro, Pasquale ^d   Gao, Wei Dong ^e   Van Eyk, Jennifer ^a   Kass, David A ^a   Wink, David A ^f   Paolocci, Nazareno ^a,g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF TURIN   (Italy)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; NITRIC OXIDE; NITROSYL HYDRIDE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR EFFECT; CONGESTIVE HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; INOTROPISM; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITROGEN OXIDES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SULFHYDRYL COMPOUNDS;

ANIMALIA;

EID: 79953775326     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3859     Document Type: Article

References (80)

1. Adak S, Wang Q, and Stuehr DJ. Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism. J Biol Chem 275: 33554-33561, 2000.
2. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favaloro JL, Triggle CR, and Kemp-Harper BK. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpo-larizing factor in resistance arteries. Br J Pharmacol 157: 540-550, 2009.
3. Bell D and McDermott BJ. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 48: 253-288, 1996. (Pubitemid 26196588)
4. Bermejo E, Saenz DA, Alberto F, Rosenstein RE, Bari SE, and Lazzari MA. Effect of nitroxyl on human platelets function. Thromb Haemost 94: 578-584, 2005. (Pubitemid 41300855)
5. Bindoli A, Fukuto JM, and Forman HJ. Thiol chemistry in peroxidase catalysis and redox signaling. Antioxid Redox Signal 10: 1549-1564, 2008. (Pubitemid 351931936)
6. Brown GC and Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 75: 283-290, 2007. (Pubitemid 46961922)
7. Bullen ML, Miller AA, Andrews KL, Irvine JC, Ritchie RH, Sobey CG, and Kemp-Harper BK. Nitroxyl (HNO) as a vasoprotective signaling molecule. Antioxid Redox Signal 14: 1675-1686, 2011.
8. Canton M, Skyschally A, Menabo R, Boengler K, Gres P, Schulz R, Haude M, Erbel R, Di LF, and Heusch G. Oxida-tive modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur Heart J 27: 875-881, 2006.
9. Cheong E, Tumbev V, Abramson J, Salama G, and Stoya-novsky DA. Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37: 87-96, 2005. (Pubitemid 39497152)
10. Choe CU, Lewerenz J, Fischer G, Uliasz TF, Espey MG, Hummel FC, King SB, Schwedhelm E, Boger RH, Gerloff C, Hewett SJ, Magnus T, and Donzelli S. Nitroxyl exacerbates ischemic cerebral injury and oxidative neurotoxicity. J Neu-rochem 110: 1766-1773, 2009.
11. Cohn JN. Inotropic therapy for heart failure: paradise lost. Eur Heart J 30: 2965-2966, 2009.
12. Cook NM, Shinyashiki M, Jackson MI, Leal FA, and Fukuto JM. Nitroxyl-mediated disruption of thiol proteins: inhibition of the yeast transcription factor Ace1. Arch Biochem Biophys 410: 89-95, 2003. (Pubitemid 36268799)
13. Dai T, Tian Y, Tocchetti CG, Katori T, Murphy AM, Kass DA, Paolocci N, and Gao WD. Nitroxyl increases force development in rat cardiac muscle. J Physiol 580: 951-960, 2007. (Pubitemid 46909044)
14. Desmard M, Boczkowski J, Poderoso J, and Motterlini R. Mitochondrial and cellular heme-dependent proteins as targets for the bioactive function of the heme oxygenase/carbon monoxide system. Antioxid Redox Signal 9: 2139-2155, 2007. (Pubitemid 350059023)
15. Dobmeier KP, Riccio DA, and Schoenfisch MH. Xerogel optical sensor films for quantitative detection of nitroxyl. Anal Chem 80: 1247-1254, 2008. (Pubitemid 351272362)
16. Donzelli S, Espey MG, Flores-Santana W, Switzer CH, Yeh GC, Huang J, Stuehr DJ, King SB, Miranda KM, and Wink DA. Generation of nitroxyl by heme protein-mediated per-oxidation of hydroxylamine but not N-hydroxy-L-arginine. Free Radic Biol Med 45: 578-584, 2008.
17. Donzelli S, Espey MG, Thomas DD, Mancardi D, Tocchetti CG, Ridnour LA, Paolocci N, King SB, Miranda KM, Laz-zarino G, Fukuto JM, and Wink DA. Discriminating formation of HNO from other reactive nitrogen oxide species. Free Radic Biol Med 40: 1056-1066, 2006. (Pubitemid 43376015)
18. Dorn GW. Adrenergic signaling polymorphisms and their impact on cardiovascular disease. Physiol Rev 90: 1013-1062, 2010.
19. Dulhunty AF, Beard NA, Pouliquin P, and Casarotto MG. Agonists and antagonists of the cardiac ryanodine receptor: potential therapeutic agents? Pharmacol Ther 113: 247-263, 2007. (Pubitemid 46149047)
20. El-Armouche A, Wahab A, Wittkopper K, Schulze T, Bottcher F, Pohlmann L, King SB, Dumond JF, Gerloff C, Boger RH, Eschenhagen T, Carrier L, and Donzelli S. The new HNO donor, 1-nitrosocyclohexyl acetate, increases contractile force in normal and beta-adrenergically desensitized ventricular myocytes. Biochem Biophys Res Commun 402: 340-344, 2010.
21. Favaloro JL and Kemp-Harper BK. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Cardiovasc Res 73: 587-596, 2007. (Pubitemid 46073951)
22. Fonarow GC. Role of carvedilol controlled-release in cardiovascular disease. Expert Rev Cardiovasc Ther 7: 483-498, 2009.
23. Froehlich JP, Mahaney JE, Keceli G, Pavlos CM, Goldstein R, Redwood AJ, Sumbilla C, Lee DI, Tocchetti CG, Kass DA, Paolocci N, and Toscano JP. Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. Biochemistry 47: 13150-13152, 2008.
24. Fukuto JM, Chiang K, Hszieh R, Wong P, and Chaudhuri G. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther 263: 546-551, 1992.
25. Fukuto JM, Jackson MI, Kaludercic N, and Paolocci N. Examining nitroxyl in biological systems. Methods Enzymol 440: 411-431, 2008.
26. Goldhaber JI and Hamilton MA. Role of inotropic agents in the treatment of heart failure. Circulation 121: 1655-1660, 2010.
27. 2+ sensitivity in human cardiomyocytes. Antioxid Redox Signal 10: 1175-1184, 2008. (Pubitemid 351620310)
28. Hobbs AJ, Fukuto JM, and Ignarro LJ. Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci USA 91: 10992-10996, 1994. (Pubitemid 24349611)
29. Hoffman MD, Walsh GM, Rogalski JC, and Kast J. Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method. Mol Cell Proteomics 8: 887-903, 2009.
30. Hool LC. The L-type Ca(2+) channel as a potential mediator of pathology during alterations in cellular redox state. Heart Lung Circ 18: 3-10, 2009.
31. Irvine JC, Gossain S, Love JE, Kaye DM, Kemp-Harper BK, and Ritchie RH. The protective role of nitroxyl (HNO) against cardiomyocyte hypertrophy via cGMP Signaling. Hypertension 53: 1109, 2009.
32. Katori T, Donzelli S, Tocchetti CG, Miranda KM, Cormaci G, Thomas DD, Ketner EA, Lee MJ, Mancardi D, Wink DA, Kass DA, and Paolocci N. Peroxynitrite and myocardial contractility: in vivo versus in vitro effects. Free Radic Biol Med 41: 1606-1618, 2006. (Pubitemid 44550084)
33. Katori T, Hoover DB, Ardell JL, Helm RH, Belardi DF, Tocchetti CG, Forfia PR, Kass DA, and Paolocci N. Calcito-nin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure. Circ Res 96: 234-243, 2005. (Pubitemid 40209371)
34. Kim WK, Choi YB, Rayudu PV, Das P, Asaad W, Arnelle DR, Stamler JS, and Lipton SA. Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron 24: 461-469, 1999. (Pubitemid 29508419)
35. Kohr MJ, Kaludercic N, Tocchetti CG, Dong GW, Kass DA, Janssen PM, Paolocci N, and Ziolo MT. Nitroxyl enhances myocyte Ca2+ transients by exclusively targeting SR Ca2+ -cycling. Front Biosci (Elite Ed) 2: 614-626, 2010.
36. Kumar MR, Fukuto JM, Miranda KM, and Farmer PJ. Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects. Inorg Chem 49: 6283-6292, 2010.
37. Kurdi M and Booz GW. JAK redux: a second look at the regulation and role of JAKs in the heart. Am J Physiol Heart Circ Physiol 297: H1545-H1556, 2009.
38. Lancel S, Zhang J, Evangelista A, Trucillo MP, Tong X, Siwik DA, Cohen RA, and Colucci WS. Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674. Circ Res 104: 720-723, 2009.
39. Lopez BE, Shinyashiki M, Han TH, and Fukuto JM. Anti-oxidant actions of nitroxyl (HNO). Free Radic Biol Med 42: 482-491, 2007.
40. Lopez BE, Wink DA, and Fukuto JM. The inhibition of glyceraldehyde-3- phosphate dehydrogenase by nitroxyl (HNO). Arch Biochem Biophys 465: 430-436, 2007. (Pubitemid 47362003)
41. Ma XL, Gao F, Liu GL, Lopez BL, Christopher TA, Fukuto JM, Wink DA, and Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci USA 96: 14617-14622, 1999. (Pubitemid 30000699)
42. Mancardi D, Ridnour L, Donzelli S, Miranda KM, Thomas DD, Katori T, Espey MG, Paolocci N, and Wink DA. The nitroxyl donors Angeli's salt and IPA/NO afford equal cardiac early preconditioning-like effect that is independent of mitochondrial K-ATP channel activation. Free Radic Biol Med 37 (Suppl. 1): S86-S87, 2004.
43. Massion PB, Pelat M, Belge C, and Balligand JL. Regulation of the mammalian heart function by nitric oxide. Comp Bio-chem Physiol A Mol Integr Physiol 142: 144-150, 2005. (Pubitemid 41443574)
44. Meissner G. Regulation of ryanodine receptor ion channels through posttranslational modifications. In: Current Topics in Membranes, vol. 66, edited by Serysheva, I. Burlington: Academic Press, 2010, pp. 91-113.
45. Miranda KM, Dutton AS, Ridnour LA, Foreman CA, Ford E, Paolocci N, Katori T, Tocchetti CG, Mancardi D, Thomas DD, Espey MG, Houk KN, Fukuto JM, and Wink DA. Mechanism of aerobic decomposition of Angeli's salt (sodium trioxodinitrate) at physiological pH. J Am Chem Soc 127: 722-731, 2005. (Pubitemid 40178747)
46. Miranda KM, Katori T, Torres de Holding CL, Thomas L, Ridnour LA, McLendon WJ, Cologna SM, Dutton AS, Champion HC, Mancardi D, Tocchetti CG, Saavedra JE, Keefer LK, Houk KN, Fukuto JM, Kass DA, Paolocci N, and Wink DA. Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo. J Med Chem 48: 8220-8228, 2005. (Pubitemid 43032530)
47. Miranda KM, Nagasawa HT, and Toscano JP. Donors of HNO. Curr Top Med Chem 5: 649-664, 2005. (Pubitemid 41179725)
48. Miranda KM, Nims RW, Thomas DD, Espey MG, Citrin D, Bartberger MD, Paolocci N, Fukuto JM, Feelisch M, and Wink DA. Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS. J Inorg Biochem 93: 52-60, 2003. (Pubitemid 36132133)
49. Nagahara N. Intermolecular disulfide bond to modulate protein function as a redox-sensing switch. Amino Acids 2010 [Epub ahead of print]; PMID: 20177947.
50. Nagahara N, Matsumura T, Okamoto R, and Kajihara Y. Protein cysteine modifications: (2) reactivity specificity and topics of medicinal chemistry and protein engineering. Curr Med Chem 16: 4490-4501, 2009.
51. Naughton P, Foresti R, Bains SK, Hoque M, Green CJ, and Motterlini R. Induction of heme oxygenase 1 by nitrosative stress. A role for nitroxyl anion. J Biol Chem 277: 40666-40674, 2002. (Pubitemid 35215648)
52. Nediani C, Raimondi L, Borchi E, and Cerbai E. Nitric oxide/ reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid Redox Signal 14: 289-331, 2011.
53. Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, and Paolocci N. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34: 33-43, 2003. (Pubitemid 36043884)
54. Paolocci N, Katori T, Champion HC, St. John ME, Miranda KM, Fukuto JM, Wink DA, and Kass DA. Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling. Proc Natl Acad Sci USA 100: 5537-5542, 2003. (Pubitemid 36542740)
55. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, and Kass DA. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci USA 98: 10463-10468, 2001. (Pubitemid 32803042)
56. Pessah IN and Feng W. Functional role of hyperreactive sulfhydryl moieties within the ryanodine receptor complex. Antioxid Redox Signal 2: 17-25, 2000. (Pubitemid 30202449)
57. Petroff MG, Kim SH, Pepe S, Dessy C, Marban E, Balligand JL, and Sollott SJ. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardio-myocytes. Nat Cell Biol 3: 867-873, 2001. (Pubitemid 32952250)
58. Pino RZ and Feelisch M. Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using L-cysteine. Bio-chem Biophys Res Commun 201: 54-62, 1994.
59. Pufahl RA, Wishnok JS, and Marletta MA. Hydrogen peroxide-supported oxidation of NG-hydroxy-L-arginine by nitric oxide synthase. Biochemistry 34: 1930-1941, 1995.
60. Queliconi BB, Wojtovich AP, Nadtochiy SM, Kowaltowski AJ, and Brookes PS. Redox regulation of the mitochondrial K(ATP) channel in cardioprotection. Biochim Biophys Acta 2010 [Epub ahead of print]; PMID: 21094666.
61. Saleem M and Ohshima H. Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme. Biochem Bio-phys Res Commun 315: 455-462, 2004. (Pubitemid 38183128)
62. Schmidt HH, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD, and Feelisch M. NO from NO synthase. Proc Natl Acad Sci USA 93: 14492-14497, 1996.
63. Sha X, Isbell TS, Patel RP, Day CS, and King SB. Hydrolysis of acyloxy nitroso compounds yields nitroxyl (HNO). J Am Chem Soc 128: 9687-9692, 2006. (Pubitemid 44147951)
64. Shiva S, Crawford JH, Ramachandran A, Ceaser EK, Hillson T, Brookes PS, Patel RP, and Darley-Usmar VM. Mechanisms of the interaction of nitroxyl with mitochondria. Bio-chem J 379: 359-366, 2004. (Pubitemid 38570109)
65. Stojanovic S, Stanic D, Nikolic M, Spasic M, and Niketic V. Iron catalyzed conversion of NO into nitrosonium (NO+) and nitroxyl (HNO/NO-) species. Nitric Oxide 11: 256-262, 2004. (Pubitemid 39573527)
66. Tao L and English AM. Protein S-glutathiolation triggered by decomposed S-nitrosoglutathione. Biochemistry 43: 4028-4038, 2004. (Pubitemid 38437069)
67. 2+ leak in chronic heart failure. Circ Res 103: 1466-1472, 2008.
68. Tocchetti CG, Mazhari R, Takimoto E, Koitabashi N, Bedja D, Gabrielson KL, Aon MA, Kass DA, and Paolocci N. Nitroxyl enhances contractility in failing isolated mouse cardiomyocytes. Circ Res 105: E60, 2009.
69. 2+ cycling. Circ Res 100: 96-104, 2007. (Pubitemid 46066777)
70. Tsihlis ND, Murar J, Kapadia MR, Ahanchi SS, Oustwani CS, Saavedra JE, Keefer LK, and Kibbe MR. Isopropy-lamine NONOate (IPA/NO) moderates neointimal hyper-plasia following vascular injury. J Vasc Surg 51: 1248-1259, 2010.
71. Ulich BL, Hollis JM, and Snyder LE. Radio detection of ni-troxyl (HNO)-1st interstellar NO bond. Astrophys J 217: L105-L108, 1977.
72. Vanuffelen BE, Van Der Zee J, De Koster BM, Vansteveninck J, and Elferink JG. Intracellular but not extracellular conversion of nitroxyl anion into nitric oxide leads to stimulation of human neutrophil migration. Biochem J 330 (Pt 2): 719-722, 1998. (Pubitemid 28111968)
73. Wink DA, Feelisch M, Fukuto J, Chistodoulou D, Jourd'heuil D, Grisham MB, Vodovotz Y, Cook JA, Krishna M, DeGraff WG, Kim S, Gamson J, and Mitchell JB. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys 351: 66-74, 1998. (Pubitemid 28373052)
74. Wong PS, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, and Nagasawa HT. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry 37: 5362-5371, 1998. (Pubitemid 28241917)
75. Wouters MA, Fan SW, and Haworth NL. Disulfides as redox switches: from molecular mechanisms to functional significance. Antioxid Redox Signal 12: 53-91, 2010.
76. Xia R, Stangler T, and Abramson JJ. Skeletal muscle ryano-dine receptor is a redox sensor with a well defined redox potential that is sensitive to channel modulators. J Biol Chem 275: 36556-36561, 2000. (Pubitemid 32002053)
77. Xu KY, Huso DL, Dawson TM, Bredt DS, and Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96: 657-662, 1999. (Pubitemid 29061264)
78. Yong QC, Hu LF, Wang S, Huang D, and Bian JS. Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl. Cardiovasc Res 88: 482-491, 2010.
79. Zgheib C, Sebastian T, Tocchetti CG, Paolocci N, King SB, Kurdi M, and Booz G. W. Nitroxyl activates redox-sensitive stress signaling in endothelial cells and has anti-inflammatory actions. Hypertension 56, e128, 2010.
80. Zhang GX, Kimura S, Nishiyama A, Shokoji T, Rahman M, Yao L, Nagai Y, Fujisawa Y, Miyatake A, and Abe Y. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 65: 230-238, 2005. (Pubitemid 40038496)